RIGL
Rigel Pharmaceuticals

12,439
Mkt Cap
$838.86M
Volume
86.00
52W High
$50.23
52W Low
$14.63
PE Ratio
8.08
RIGL Fundamentals
Price
$49.80
Prev Close
$46.22
Open
$46.51
50D MA
$33.07
Beta
1.18
Avg. Volume
464,459.00
EPS (Annual)
$0.9886
P/B
7.68
Rev/Employee
$1.09M
Loading...
Loading...
News
all
press releases
37,269 Shares in Rigel Pharmaceuticals, Inc. $RIGL Acquired by Sierra Summit Advisors LLC
Sierra Summit Advisors LLC purchased a new stake in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) in the second quarter, according to its most recent disclosure with the SEC. The...
MarketBeat·21h ago
News Placeholder
More News
News Placeholder
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Get Free Report) has earned an average recommendation of "Moderate Buy" from the seven analysts that are currently covering the stock, MarketBeat Ratings...
MarketBeat·1d ago
News Placeholder
Rigel Pharmaceuticals, Inc. $RIGL Stake Boosted by Hillsdale Investment Management Inc.
Hillsdale Investment Management Inc. lifted its stake in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) by 36.4% during the second quarter, according to its most recent filing with...
MarketBeat·2d ago
News Placeholder
LSV Asset Management Buys Shares of 95,700 Rigel Pharmaceuticals, Inc. $RIGL
LSV Asset Management bought a new position in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) in the second quarter, according to the company in its most recent 13F filing with the...
MarketBeat·2d ago
News Placeholder
Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Up 5% - Still a Buy?
Rigel Pharmaceuticals (NASDAQ:RIGL) Trading 5% Higher - Here's Why...
MarketBeat·4d ago
News Placeholder
Rigel Pharmaceuticals (NASDAQ:RIGL) Trading Down 8% - Here's What Happened
Rigel Pharmaceuticals (NASDAQ:RIGL) Trading Down 8% - Should You Sell...
MarketBeat·5d ago
News Placeholder
Rigel Pharmaceuticals (NASDAQ:RIGL) Sets New 12-Month High - Here's What Happened
Rigel Pharmaceuticals (NASDAQ:RIGL) Sets New 1-Year High - Still a Buy...
MarketBeat·6d ago
News Placeholder
Rigel Announces Publication of Final 5-year Data on REZLIDHIA (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology
Rigel Announces Publication of Final 5-year Data on REZLIDHIA (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology Rigel Announces Publication of Final 5-year Data on...
PR Newswire·8d ago
News Placeholder
Rigel Pharmaceuticals (NASDAQ:RIGL) Stock Price Up 9.4% - Still a Buy?
Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Up 9.4% - Time to Buy...
MarketBeat·13d ago
News Placeholder
Rigel to Present at the Jefferies Global Healthcare Conference in London
Rigel to Present at the Jefferies Global Healthcare Conference in London Rigel to Present at the Jefferies Global Healthcare Conference in London PR Newswire SOUTH SAN FRANCISCO, Calif., Nov. 12...
PR Newswire·13d ago

Latest RIGL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.